Lyle Small, founder of Chromatic Technologies, Inc. (CTI), has dedicated over three decades to pioneering interactive inks and coatings advancements. With a visionary focus, Lyle's leadership has propelled CTI to the forefront of innovation in the printing industry, boasting over 35 unique technologies, including thermochromic, barochromic, hydrochromic, photochromic, and Glow-in-the-Dark ink.

​

His exceptional contributions extend beyond commercial success, as evidenced by his groundbreaking work in cancer research. As the founder and CEO of Lahjavida, Inc., Lyle has patented revolutionary technologies to revolutionize cancer treatment. By combining tumor-targeting dyes with therapeutic agents like chemotherapy drugs, his work shows promising results in targeting and eliminating cancer cells, offering hope for more effective treatments.

​

Lyle's unwavering commitment to pushing the boundaries of possibility continues to inspire transformative change in the critical field of cancer research.